BEAM
Price
$27.50
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
109 days until earnings call
SNDX
Price
$16.79
Change
+$0.16 (+0.96%)
Updated
Nov 14 closing price
110 days until earnings call
Ad is loading...

BEAM vs SNDX

Header iconBEAM vs SNDX Comparison
Open Charts BEAM vs SNDXBanner chart's image
Beam Therapeutics
Price$27.50
Change-$0.00 (-0.00%)
Volume$822.51K
CapitalizationN/A
Syndax Pharmaceuticals
Price$16.79
Change+$0.16 (+0.96%)
Volume$2.19M
CapitalizationN/A
BEAM vs SNDX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. SNDX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and SNDX is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BEAM: $27.50 vs. SNDX: $16.63)
Brand notoriety: BEAM and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 83% vs. SNDX: 247%
Market capitalization -- BEAM: $2.18B vs. SNDX: $1.43B
BEAM [@Biotechnology] is valued at $2.18B. SNDX’s [@Biotechnology] market capitalization is $1.43B. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than SNDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while SNDX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • SNDX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than SNDX.

Price Growth

BEAM (@Biotechnology) experienced а +3.31% price change this week, while SNDX (@Biotechnology) price change was -22.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.83%. For the same industry, the average monthly price growth was +3.51%, and the average quarterly price growth was +5.54%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

SNDX is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-1.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.18B) has a higher market cap than SNDX($1.43B). BEAM YTD gains are higher at: 1.029 vs. SNDX (-23.045).
BEAMSNDXBEAM / SNDX
Capitalization2.18B1.43B152%
EBITDAN/AN/A-
Gain YTD1.029-23.045-4%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
53
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMSNDX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 7 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SNDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X90584.1640002628.351600
+2.99%
Bitcoin cryptocurrency
TSLA330.241.75
+0.53%
Tesla
AAPL225.120.89
+0.40%
Apple
SPY597.190.29
+0.05%
SPDR® S&P 500® ETF Trust
GME26.46-0.38
-1.42%
GameStop Corp

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-1.57%
CRSP - BEAM
75%
Closely correlated
-1.85%
NTLA - BEAM
67%
Closely correlated
-3.24%
DNLI - BEAM
64%
Loosely correlated
-0.87%
EDIT - BEAM
64%
Loosely correlated
-3.58%
RXRX - BEAM
62%
Loosely correlated
-3.43%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with ABOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
+2.59%
ABOS - SNDX
49%
Loosely correlated
-5.42%
KRYS - SNDX
46%
Loosely correlated
-1.60%
RCUS - SNDX
45%
Loosely correlated
-2.03%
BEAM - SNDX
45%
Loosely correlated
-1.57%
PLRX - SNDX
45%
Loosely correlated
-0.36%
More